BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19586941)

  • 1. Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.
    Kristinsson SY; Goldin LR; Björkholm M; Koshiol J; Turesson I; Landgren O
    Haematologica; 2009 Nov; 94(11):1581-9. PubMed ID: 19586941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.
    Landgren O; Kristinsson SY; Goldin LR; Caporaso NE; Blimark C; Mellqvist UH; Wahlin A; Bjorkholm M; Turesson I
    Blood; 2009 Jul; 114(4):791-5. PubMed ID: 19182202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal gammopathies of undetermined significance].
    Zandecki M; Geneviève F; Jego P; Grosbois B
    Rev Med Interne; 2000 Dec; 21(12):1060-74. PubMed ID: 11191674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of monoclonal gammopathy].
    Huijgens PC; Zweegman S
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1401-2. PubMed ID: 12174432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
    Schmalzing M; Tony HP; Knop S
    Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphoproliferative syndromes associated with rheumatoid arthritis].
    Roldán MR; Román J; González J
    An Med Interna; 1992 Aug; 9(8):396-400. PubMed ID: 1391564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gougerot-Sjögren syndrome and malignant lymphoproliferative syndromes].
    Grosbois B; Jego P; Leblay R
    Rev Med Interne; 1998 May; 19(5):319-24. PubMed ID: 9775165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hematopoietic malignancies in a well-defined population in France.
    Carli PM; Milan C; Lorenzini JL; Guy H; Michiels R
    Oncology; 1986; 43(6):354-7. PubMed ID: 3808567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
    Subramaniam K; D'Rozario J; Pavli P
    J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
    Caviglia GP; Sciacca C; Abate ML; Olivero A; Rosso C; Touscoz GA; Ciancio A; Rizzetto M; Smedile A
    J Gastroenterol Hepatol; 2015 Apr; 30(4):742-7. PubMed ID: 25351042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing incidence of lymphoproliferative disorders in Yorkshire.
    Jack AS; Morgan GJ; Clayden D; McNally R; Thomas J; Cartwright R
    Clin Lab Haematol; 1998 Oct; 20(5):289-95. PubMed ID: 9807676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmablastic myeloma/leukemia variant of monomorphic posttransplant lymphoproliferative disorder.
    Zhao Y; Wang E
    Blood; 2021 Oct; 138(16):1510. PubMed ID: 34673946
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
    Sugai S; Shimizu S; Konda S
    Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
    Lolin YI; Chow J; Wickham NW
    Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of shared idiotypes by paraproteins from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Berenson JR; Lichtenstein A; Hart S; Palomares D; Miller RA
    Blood; 1990 Jun; 75(11):2107-11. PubMed ID: 1693294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.